Scholars Central

ArticlePublished 30 Dec 2023

Hederagenin Inhibits the Proliferation, Migration and Invasion of Laryngeal Squamous Cell Carcinoma TU177 Cells by regulating microRNA-1269 Expression

Authors: Hui Peng, Shanshan Liu, Zhibing Lu, Jiyong Peng, Zhi Wang

Indian Journal of Pharmaceutical Sciences

Volume 85 · Issue 6 · Pages 1640–1647

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

To investigate the anti-cancer effect and mechanism of hederagenin on laryngeal squamous cell carcinoma cells. Laryngeal squamous cell carcinoma cells TU177 were divided into control group, hederagenin group (5, 10, 20 μM hederagenin), anti-microRNA-negative control group (transfected with anti-microRNA-negative control), anti-microRNA-1269 group (transfected with anti-microRNA-1269), hederagenin+microRNA-negative control group (transfected with microRNA-negative control, 20 μM hederagenin), hederagenin+microRNA-1269 group (transfected with microRNA-1269 mimics, 20 μM hederagenin). We used cell counting kit-8 and a plate replicating experiment to determine TU177 cell proliferation; the wound recuperation test to examine TU177 cell migration; the Transwell assay to identify TU177 cell assault; the Western blotting method to examine N and E-cadherin protein communication; and reverse transcription-quantitative polymerase chain reaction to evaluate microRNA-1269 expressing themselves. Compared with the control group, the inhibition rate (14.81±1.26) %, (32.94±3.22) %, (57.74±4.29) % vs. (0.00±0.00) % and E-cadherin protein expression of TU177 cells in the hederagenin (5, 10, 20 μM) group were notably increased (p<0.05), the number of clone formation, the invasion number (85.88±7.36) individuals, (70.67±5.37) individuals, (52.23±5.05) individuals vs. (119.34±12.89) individuals and the scratch healing rate [(56.91±4.85) %, (38.93±3.31) %, (24.22±2.19) % vs. (72.16±5.66) %], N-cadherin protein expression and microRNA-1269 expression [(0.77±0.06), (0.58±0.05), (0.38±0.04) vs. (1.00±0.00)] were notably reduced (p<0.05). Inhibition of cells was much higher in the anti-microRNA-negative control group [(48.98±4.62) % vs. (5.89±0.48) %], E-cadherin protein expression of TU177 in anti-microRNA-1269 group were notably increased (p<0.05), the number of clone formation, the invasion number [(61.36±5.13) individual vs. (118.02±11.84) individual], and the scratch healing rate (33.28±3.02) % vs. (73.11±6.39) %, N-cadherin protein expression were notably reduced (p<0.05). The rate of inhibition was much lower in the hederagenin+microRNA-negative control group (19.62±1.16) % vs. (58.35±4.72) % and E-cadherin protein expression of TU177 in the hederagenin+microRNA-1269 group were notably reduced (p<0.05), the number of clone formation, the invasion number [(91.94±7.83) individuals vs. (50.74±5.01) individuals], and the scratch healing rate (58.02±4.36) % vs. (23.07±3.02) %, N-cadherin protein expression were notably increased (p<0.05). Hederagenin has anti-proliferation, anti-migration and anti-invasion impacts on TU177 laryngeal squamous cell carcinoma cells by repressing microRNA-1269 expression.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalIndian Journal of Pharmaceutical Sciences
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Hui Peng”
  • BylineArticles whose byline prints “Shanshan Liu”
  • BylineArticles whose byline prints “Zhibing Lu”
  • BylineArticles whose byline prints “Jiyong Peng”
  • BylineArticles whose byline prints “Zhi Wang”